Found 50 matching trials
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma PHASE1 The prognosis of pancreatic cancer is extremely poor. Current guidelines re...
Show More Location
The second affiliated hospital of Zhejiang University
Learn More & Join Trial
The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer. N/A Ampullary adenocarcinoma (AAC) is a rare gastrointestinal cancer with varyi...
Show More Location
Fondazione Poliambulanza
Learn More & Join Trial
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer PHASE2 The purpose of this study is to evaluate the efficacy of mFOLFIRINOX plus r...
Show More Location
Shanghai Cancer Center
Learn More & Join Trial
Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy. PHASE3 The main purpose of
* To observe the overall survival of patients with res...
Show More Location
Multiple Locations
Learn More & Join Trial
Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) PHASE3 The main aim of this study is to compare the efficacy of short-course versu...
Show More Status
Active Not Recruiting
Location
Oncologia Medica e Prevenzione Oncologica Centro di riferimento oncologico (CRO), IRCCS
Learn More & Join Trial
A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab PHASE1 This is an open-label, phase 1/2, multiple-indication platform study to exp...
Show More Status
Active Not Recruiting
Location
Nationales Centrum für Tumorerkrankungen Heidelberg
Learn More & Join Trial
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy PHASE2 The purpose of this study is to evaluate the efficacy of mFOLFIRINOX plus r...
Show More Location
Shanghai Cancer Center
Learn More & Join Trial
mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer PHASE1 This study is a prospective, single-arm, multicenter, phase Ib/II clinical ...
Show More Location
First Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors PHASE1 The purpose of this platform study is to evaluate the safety, tolerability,...
Show More Location
Ironwood Cancer and Research Centers
Learn More & Join Trial